Controlled preventive treatment of tuberculosis in childhood
DOI:
https://doi.org/10.52692/1857-0011.2024.2-79.17Keywords:
controlled preventive treatment of tuberculosis, children, criteria of effectiveness and safetyAbstract
Introduction. Controlled tuberculosis preventive treatment (TPT) significantly reduces the risk of developing tuberculosis (TB) in children who adhere to therapy. Objectives. Based on a set of criteria, to evaluate the efficacy and safety of controlled TPT in children depending on the epidemiological environment Materials and methods. The study included 178 children diagnosed with tuberculosis infection (TI). Children with controlled TPT were divided into 2 groups: Group I (n=77) - without contact with a TB patient, Group II (n=53) - having contact with a TB patient. Children whose parents refused TPT (n=48) constituted group III. Statistical processing - SPSS17.0 program.Results. No cases of TB were recorded in groups I and II. The disease was detected in 8 children of group III. The completeness and continuity of TPT in children of groups I and II was 100%. The decrease in the sensitivity of the test with recombinant tuberculosis allergen was 88.3% in children of group I, 81.1% in group II and 12.5% of children whose parents refused TPT (PI-III<0.05, χ2= 70.4). The tolerability of anti - tuberculosis drugs (ATD) in children of groups I and II was satisfactory.Conclusions. High efficiency and safety of controlled TPT have been established both in children from TI foci and in those with unspecified tuberculosis contact.
References
Овсянкина ЕС, Панова ЛВ, Хитева АЮ и др. Причины поздней диагностики туберкулеза у подростков. Российский вестник перинатологии и педиатрии. 2019;64(1):76-80.
Усачева НЭ, Мякишева ТВ, Новиков ВЕ. Иммунодиагностика туберкулезной инфекции у детей. Вестник Смоленской государственной медицинской академии. 2021;20(1): 101-106.
Ставицкая НВ. Исследование генетических фак- торов у детей с латентной туберкулезной инфекцией. Фундаментальные исследования. 2010;5:53-59.
Богородская ЕМ, Литвинов ВИ. Латентная туберкулезная инфекция: место в спектре туберкулеза, проблемы. Туберкулез и социально значимые заболевания. 2024;12(1):48-55.
Глушаков ИА, Лозовская МЭ, Гуткин МГ и др. Латентная туберкулезная инфекция у детей и подростков: вопросы превентивного лечения. Children’s Medicine of the North-West. 2024;12( 2): 187-194.
Baryakova TH, Pogostin BH, Langer R, et al. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22(5):387–409.
Клинические рекомендации: Латентная туберкулезная инфекция у детей. Общероссийская общественная организация «Российское общество фтизиатров». 2024 http://roftb.ru/structure/
Tayal A, Kabra SK. Tuberculosis Preventive Treatment. Indian J Pediatr. 2024; 91:823–829. https://doi.org/10.1007/s12098-023-04969-z
Ходоренко ВА, Яровая ЮА, Лозовская МЭ, и др. Оценка приверженности родителей к специфическому лечению детей, больных туберкулезом. Children’s medicine of the North-West. 2023; 11 (3): 125–130.
Downloads
Published
License
Copyright (c) 2025 Bulletin of the Academy of Sciences of Moldova. Medical Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.